Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-06-02 Sale |
2022-06-02 4:48 pm |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru SVP and General Counsel |
1,795 | $19.73 | $35,419 | 16,380 (Direct) |
View |
| 2022-06-01 Sale |
2022-06-02 4:48 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,500 | $20.62 | $51,539 | 248,365 (Indirect Direct) |
View |
| 2022-05-05 Sale |
2022-05-05 5:31 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $21.76 | $21,760 | 876,681 (Indirect Direct) |
View |
| 2022-05-02 Sale |
2022-05-03 5:14 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,500 | $20.44 | $51,112 | 256,975 (Indirect Direct) |
View |
| 2022-04-21 Sale |
2022-04-21 6:32 pm |
Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer |
2,197 | $20.42 | $44,872 | 257,229 (Direct) |
View |
| 2022-04-06 Sale |
2022-04-08 6:06 pm |
Arcutis Biotherapeutics Inc. | ARQT | ORBIMED ADVISORS LLC ORBIMED CAPITAL LLC OrbiMed Capital GP VII LLC 10% Owner |
878,200 | $20.68 | $18,163,608 | 451,086 (Indirect) |
View |
| 2022-04-05 Sale |
2022-04-05 6:45 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $21.43 | $21,430 | 877,681 (Indirect Direct) |
View |
| 2022-04-01 Sale |
2022-04-01 4:55 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
7,500 | $20.02 | $150,184 | 214,493 (Indirect Direct) |
View |
| 2022-03-09 Sale |
2022-03-11 9:42 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
300 | $17 | $5,100 | 878,681 (Indirect Direct) |
View |
| 2022-03-04 Sale |
2022-03-07 8:59 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
3,259 | $16.9 | $55,088 | 1,186,016 (Indirect Direct) |
View |
| 2022-03-04 Sale |
2022-03-07 8:53 pm |
Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks |
1,011 | $16.85 | $17,032 | 90,139 (Direct) |
View |
| 2022-03-04 Sale |
2022-03-07 8:49 pm |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
1,023 | $16.85 | $17,234 | 79,311 (Direct) |
View |
| 2022-03-04 Sale |
2022-03-07 8:49 pm |
Arcutis Biotherapeutics Inc. | ARQT | Burrows Scott L Chief Financial Officer |
303 | $16.85 | $5,104 | 70,556 (Direct) |
View |
| 2022-03-04 Sale |
2022-03-07 8:48 pm |
Arcutis Biotherapeutics Inc. | ARQT | Turney Patricia A. SVP, Operations |
1,023 | $16.85 | $17,234 | 66,413 (Direct) |
View |
| 2022-03-04 Sale |
2022-03-07 8:47 pm |
Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer |
856 | $16.85 | $14,420 | 294,726 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-03 4:18 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
2,153 | $17.75 | $38,222 | 810,640 (Indirect Direct) |
View |
| 2022-03-01 Sale |
2022-03-03 4:18 pm |
Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer |
775 | $17.75 | $13,758 | 246,982 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-03 4:17 pm |
Arcutis Biotherapeutics Inc. | ARQT | Burrows Scott L Chief Financial Officer |
420 | $17.75 | $7,456 | 22,259 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-03 4:16 pm |
Arcutis Biotherapeutics Inc. | ARQT | Turney Patricia A. SVP, Operations |
936 | $17.75 | $16,617 | 18,836 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-03 4:15 pm |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
935 | $17.75 | $16,599 | 31,734 (Direct) |
View |
| 2022-02-09 Sale |
2022-02-11 5:55 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $17 | $17,000 | 932,428 (Indirect Direct) |
View |
| 2022-01-05 Sale |
2022-01-07 4:17 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $21.59 | $21,592 | 933,428 (Indirect Direct) |
View |
| 2022-01-03 Sale |
2022-01-05 5:19 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,500 | $21.21 | $53,030 | 221,993 (Indirect Direct) |
View |
| 2021-12-27 Sale |
2021-12-28 5:00 pm |
Arcutis Biotherapeutics Inc. | ARQT | Burrows Scott L Chief Financial Officer |
12,560 | $20.07 | $252,139 | 22,679 (Direct) |
View |
| 2021-12-23 Sale |
2021-12-23 9:46 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,500 | $20.16 | $50,396 | 224,493 (Indirect Direct) |
View |
| 2021-12-08 Sale |
2021-12-10 6:41 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $17 | $17,000 | 934,428 (Indirect Direct) |
View |
| 2021-11-05 Sale |
2021-11-09 5:19 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $21.5 | $21,502 | 935,428 (Indirect Direct) |
View |
| 2021-11-01 Sale |
2021-11-03 5:16 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,500 | $21.81 | $54,524 | 226,993 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-06-01 Option Award |
2022-06-03 4:54 pm |
N/A 2032-06-01 |
Arcutis Biotherapeutics Inc. | ARQT | LIN SUE-JEAN Director |
16,108 | $0 | 16,408 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-03 4:53 pm |
N/A 2032-06-01 |
Arcutis Biotherapeutics Inc. | ARQT | Heron Patrick J Director 10% Owner |
16,108 | $0 | 16,108 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-03 4:52 pm |
N/A 2032-06-01 |
Arcutis Biotherapeutics Inc. | ARQT | Leonard Keith R Director |
16,108 | $0 | 17,858 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-03 4:51 pm |
N/A 2032-06-01 |
Arcutis Biotherapeutics Inc. | ARQT | TURNER JOSEPH L Director |
16,108 | $0 | 16,108 (Direct) |
View |
| 2022-05-27 Option Award |
2022-06-02 4:48 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru SVP and General Counsel |
4,875 | $0 | 16,380 (Direct) |
View |
| 2022-06-01 Exercise |
2022-06-02 4:48 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,500 | $1.6806 | 248,365 (Direct) |
View |
| 2022-06-01 Exercise |
2022-06-02 4:48 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,500 | $0 | 248,365 (Direct) |
View |
| 2022-05-02 Exercise |
2022-05-03 5:14 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,004 | $1.6806 | 256,975 (Direct) |
View |
| 2022-05-02 Exercise |
2022-05-03 5:14 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,496 | $0.5802 | 256,975 (Direct) |
View |
| 2022-05-02 Exercise |
2022-05-03 5:14 pm |
N/A 2028-06-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,500 | $0 | 256,975 (Direct) |
View |
| 2022-04-01 Exercise |
2022-04-01 4:55 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
7,500 | $0.5802 | 214,493 (Direct) |
View |
| 2022-04-01 Exercise |
2022-04-01 4:55 pm |
N/A 2028-06-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
7,500 | $0 | 214,493 (Direct) |
View |
| 2022-03-23 Exercise(A) |
2022-03-30 8:02 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Turney Patricia A. SVP, Operations |
25,328 | $6.52 | 191,056 (Direct) |
View |
| 2022-03-23 Exercise(A) |
2022-03-30 8:02 pm |
N/A 2029-11-20 |
Arcutis Biotherapeutics Inc. | ARQT | Turney Patricia A. SVP, Operations |
25,328 | $0 | 191,056 (Direct) |
View |
| 2022-03-23 Option Award |
2022-03-25 4:11 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Turney Patricia A. SVP, Operations |
25,328 | $6.52 | 191,056 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 8:59 pm |
N/A 2032-03-03 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
259,000 | $0 | 1,186,016 (Direct) |
View |
| 2022-03-07 Exercise |
2022-03-07 8:59 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
700 | $1.6806 | 1,186,016 (Direct) |
View |
| 2022-03-07 Exercise |
2022-03-07 8:59 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
700 | $0 | 1,186,016 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 8:53 pm |
N/A 2032-03-03 |
Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks |
64,900 | $0 | 90,139 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 8:52 pm |
N/A 2032-03-03 |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru SVP and General Counsel |
48,600 | $0 | 48,600 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 8:49 pm |
N/A 2032-03-03 |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
48,600 | $0 | 79,311 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 8:49 pm |
N/A 2032-03-03 |
Arcutis Biotherapeutics Inc. | ARQT | Burrows Scott L Chief Financial Officer |
48,600 | $0 | 70,556 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 8:48 pm |
N/A 2032-03-03 |
Arcutis Biotherapeutics Inc. | ARQT | Turney Patricia A. SVP, Operations |
48,600 | $0 | 66,413 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 8:47 pm |
N/A 2032-03-03 |
Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer |
48,600 | $0 | 294,726 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 8:46 pm |
N/A 2032-03-03 |
Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard SVP and Chief Business Officer |
48,600 | $0 | 48,600 (Direct) |
View |
| 2022-02-09 Exercise |
2022-02-11 5:55 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $1.6806 | 932,428 (Direct) |
View |
| 2022-02-09 Exercise |
2022-02-11 5:55 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $0 | 932,428 (Direct) |
View |
| 2022-01-05 Exercise |
2022-01-07 4:17 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $1.6806 | 933,428 (Direct) |
View |
| 2022-01-05 Exercise |
2022-01-07 4:17 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $0 | 933,428 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 7:43 pm |
N/A 2032-01-03 |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru SVP and General Counsel |
185,000 | $0 | 185,000 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-05 5:19 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,500 | $0.5802 | 221,993 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-05 5:19 pm |
N/A 2028-06-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,500 | $0 | 221,993 (Direct) |
View |
| 2021-12-30 Option Award |
2022-01-04 9:05 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks |
16,750 | $0 | 26,250 (Direct) |
View |
| 2021-12-30 Option Award |
2022-01-04 9:05 pm |
N/A 2031-08-23 |
Arcutis Biotherapeutics Inc. | ARQT | Burrows Scott L Chief Financial Officer |
55,704 | $0 | 55,704 (Direct) |
View |
| 2021-12-23 Exercise |
2021-12-23 9:46 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,500 | $0.5802 | 224,493 (Direct) |
View |
| 2021-12-23 Exercise |
2021-12-23 9:46 pm |
N/A 2028-06-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,500 | $0 | 224,493 (Direct) |
View |
| 2021-12-08 Exercise |
2021-12-10 6:41 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $1.6806 | 934,428 (Direct) |
View |
| 2021-12-08 Exercise |
2021-12-10 6:41 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $0 | 934,428 (Direct) |
View |
| 2021-11-05 Exercise |
2021-11-09 5:19 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $1.6806 | 935,428 (Direct) |
View |
| 2021-11-05 Exercise |
2021-11-09 5:19 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $0 | 935,428 (Direct) |
View |
| 2021-11-01 Exercise |
2021-11-03 5:16 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,500 | $0.5802 | 226,993 (Direct) |
View |
| 2021-11-01 Exercise |
2021-11-03 5:16 pm |
N/A 2028-06-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,500 | $0 | 226,993 (Direct) |
View |